White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study
- Frans Verhey (f.verhey{at}np.unimaas.nl)
- Giovanni Frisoni (gfrisoni{at}oh-fbf.it)
- magda tsolaki (tsolakim{at}hellasnet.gr)
- Aristotle University of Thessaloniki, Memory and Dementia Centre, 3rd Department of Neurology, G. Pa, Greece
- Panagiota Papapostoulou (papapostoula{at}hotmail.com)
- Flavio Nobili (flaviomariano.nobili{at}hsanmartino.liguria.it)
- Clinical Neurophysiology Service, Dept of Endocrinological and Metabolic Sciences, University of Ge, Italy
- Lars-Olof Wahlund (lars-olof.wahlund{at}neurotec.ki.se)
- Lennart Minthon (lennart.minthon{at}skane.se)
- Lutz Frolich (froelich{at}zi-mannheim.de)
- Dept of Geriatric Psychiatry, Zentralinstitut für Seelische Gesundheit, University of Heidelberg, Ma, Germany
- Harald Hampel (hampel{at}med.uni-muenchen.de)
- Alzheimer Memorial Centre and Geriatric Psychiatry Branch, Dementia and Neuroimaging Section Departm, Germany
- Hilkka Soininen (hilkka.soininen{at}uku.fi)
- dirk knol (d.knol{at}vumc.nl)
- Frederik Barkhof (f.barkhof{at}vumc.nl)
- philip scheltens (p.scheltens{at}vumc.nl)
Abstract
Clinical subtypes of mild cognitive impairment (MCI) may represent different underlying aetiologies. In a European, multi-center, memory-clinic based study (DESCRIPA) of non-demented subjects we investigated whether MCI subtypes have different brain correlates on MRI and whether the relation between subtypes and brain pathology is modified by age. Using visual rating scales medial temporal lobe atrophy (MTA) (0-4) and white matter hyperintensities (WMH) (0-30) were assessed. Severity of MTA differed between MCI subtypes (p<0.001), increasing from (mean±standard deviation) 0.8±0.7 in subjective complaints (n=77), to 1.3±0.8 in non-amnestic MCI (n=93), 1.4±0.9 in single-domain amnestic MCI (n=70) and 1.7±0.9 in multiple-domain amnestic MCI (n=89). The association between MCI subtype and MTA was modified by age, and mainly present in subjects >70 years. Severity of WMH didn’t differ between MCI subtypes (p=0.21), However, the combination of MTA and WMH differed between MCI subtypes (p=0.02) We conclude that MCI subtypes may have different brain substrates, especially in older subjects. Isolated MTA was mainly associated with amnestic MCI subtypes, suggesting AD as underlying cause. In non-amnestic MCI the relatively higher prevalence of MTA in combination with WMH may suggest a different pathophysiological origin.







